Globus Medical, Inc.
Globus Medical, Inc. (NYSE: GMED) develops and commercializes medical devices and healthcare solutions for musculoskeletal disorders, serving hospitals, ambulatory surgery centers and physicians. It operates as one reportable segment and organizes its portfolio into Musculoskeletal Solutions and Enabling Technologies.… From the company’s description.
Over the twelve months to Sep 30, 2026, Globus Medical, Inc. reported revenue of $3.14B, up 13.4% from a year earlier, and net income of $557.64M. Its operating margin was 21.6%, and operations generated $925.92M in cash. In fiscal 2025, it reported revenue of $2.94B, up 16.7% from fiscal 2024, and net income of $537.87M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Globus Medical, Inc. does
In the company’s own words
Globus Medical, Inc. (NYSE: GMED) develops and commercializes medical devices and healthcare solutions for musculoskeletal disorders, serving hospitals, ambulatory surgery centers and physicians. It operates as one reportable segment and organizes its portfolio into Musculoskeletal Solutions and Enabling Technologies. Musculoskeletal Solutions include spinal and orthopedic implants, biologics, surgical instruments, spinal cord stimulation therapies and neuromonitoring services; Enabling Technologies include imaging, navigation and robotic systems for spine, cranial and orthopedic surgery. Products include the Excelsius robotics and navigation platform, HFX spinal cord stimulation system, PRECICE limb reconstruction platform and ANTHEM fracture plating system. Globus sells primarily through direct and distributor sales teams, with hip and knee products marketed mainly through independent sales agents. Its 2023 acquisition of NuVasive expanded its spine portfolio and global commercial reach, while its 2025 acquisition of Nevro added chronic-pain therapies and sacroiliac joint treatment options. In fiscal 2025, the company launched nine products and had sales operations in 65 countries. Its website is www.globusmedical.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- AUDUBON, PA
- Fiscal year end
- December
- CIK
- 1237831
- SIC
- 3841
Financial performance, year by year
Fiscal 2012–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Globus Medical, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Globus Medical, Inc. · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Globus Medical, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Globus Medical, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Globus Medical, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Globus Medical, Inc.'s last four quarterly filings that the numbers alone won't show?”